M. Gilligan

Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium.

P. Searle, P. Gerin, M. Al‐Rubeai, 1999, Human gene therapy.

Gene Therapy: Development of Immunostimulatory Treatments for Cancer

P. Searle, M. Gilligan, P. Knox, 2000, Biotechnology & genetic engineering reviews.

Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase gene.

D. Kerr, I. McNeish, C. Springer, 1998, Advances in experimental medicine and biology.

Monoclonal antibodies to ros 17/2.8 cells recognize antigens, some of which are restricted to osteoblasts and chondrocytes

D. Heath, E. Green, H. Docherty, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Adenoviral delivery of B7–1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells

D. Kerr, P. Searle, R. Barton, 1998, Gene Therapy.

Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954

I. McNeish, V. Mautner, V Mautner, 1998, Gene Therapy.

Production and characterisation of monoclonal antibodies to parathyroid hormone-related protein.

J. Ratcliffe, D. Heath, W. Ratcliffe, 1990, Journal of immunological methods.